Cannabis Strategic Ventures (NUGS) P/S Ratio
Cannabis Strategic Ventures (NUGS) has a price-to-sales ratio of 4.78x, placing it in the Premium range for cannabis stocks. The company has a market cap of $4.04B and TTM revenue of $446.2M. Revenue is growing 28.3% YoY.
P/S Ratio (TTM)
4.78x
EV/Revenue
12.80x
Market Cap
$4.04B
Revenue Growth
+28.3%
Valuation Breakdown
| Metric | Value |
|---|---|
| Stock Price | $73.74 |
| Market Capitalization | $4.04B |
| TTM Revenue | $446.2M |
| Price-to-Sales (TTM) | 4.78x |
| EV/Revenue | 12.80x |
| Revenue Growth (YoY) | +28.3% |
| Gross Margin | 23.3% |
| Sector | MSO |
| Exchange | OTC |
| Valuation Range | Premium |
Frequently Asked Questions
What is NUGS's current price-to-sales ratio?+
The price-to-sales (P/S) ratio divides Cannabis Strategic Ventures's market capitalization by its trailing twelve months of revenue. Since many cannabis companies are not yet profitable, P/S is one of the most widely used valuation metrics in the sector. A lower ratio may suggest the stock is undervalued relative to revenue.
How does NUGS's P/S compare to other cannabis stocks?+
P/S ratios in cannabis typically range from 0.5x to 5x depending on growth rate, profitability, and market sentiment. High-growth companies command higher multiples, while mature, lower-growth companies trade at lower multiples. Compare Cannabis Strategic Ventures to peers in the same sub-sector (MSO, LP, ancillary) for meaningful context.
Is NUGS overvalued or undervalued based on P/S?+
A single metric like P/S cannot definitively determine if Cannabis Strategic Ventures is over- or undervalued. Consider P/S alongside revenue growth rate, gross margins, cash position, and competitive dynamics. A company growing revenue at 50% YoY may justify a higher P/S than one growing at 5%. Also consider enterprise value-to-revenue (EV/Revenue) which accounts for debt and cash.